Anti-miRNA-23a Oligonucleotide Suppresses Glioma Cells Growth by Targeting Apoptotic Protease Activating Factor-1

E-ISSN： 1873-4286|19|35|6382-6389

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.35, 2013-10, pp. : 6382-6389

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting miR-21 in glioma: a small RNA with big potential

By Moore Lynette M Zhang Wei

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 11, 2010-11 ,pp. : 1247-1257

Informa Healthcare

Access to resources Recommend Favorite

Oligonucleotide Aptamers for Glioma Targeting: An Update

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 15, Iss. 2, 2015-08 ,pp. : 126-137

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting malignant glioma cells in vitro using platelet-derived growth factor AA-based conjugates

By Wester Maria Dahlstrom Wasteson Åke Lindstrom Annelie

Journal of Drug Targeting, Vol. 17, Iss. 4, 2009-05 ,pp. : 268-277

Informa Healthcare

Access to resources Recommend Favorite

RNA Interference in Cancer: Targeting the Anti-Apoptotic Protein c-FLIP for Drug Discovery

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 6, 2009-06 ,pp. : 741-748

Bentham Science Publishers

Access to resources Recommend Favorite

A Direct Comparison of Anti-microRNA Oligonucleotide Potency

By Lennox Kim Behlke Mark

Pharmaceutical Research, Vol. 27, Iss. 9, 2010-09 ,pp. : 1788-1799

Springer Publishing Company

Access to resources Recommend Favorite